Diabetes

Diabetes is a disease in which the body is unable to property regulate insulin. It can be either Type 1 or Type 2 diabetes, both of which have been studied extensively. Diabetes alters the way your body deals with sugars in the blood stream, and is very dangerous if left untreated. The disease can end in organ damage and extremity amputation. Diabetes was the seventh leading cause of death in the United States in 2010.

Further information about diabetes can be found by clicking this link.

Below are some studies looking the use of CBD in diabetes treatment.

General Information
Scientific Research

The Impact of Marijuana Use on Glucose, Insulin, and Insulin Resistance among US Adults

http://www.amjmed.com/article/S0002-9343%2813%2900200-3/abstract

 

Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy

https://www.ncbi.nlm.nih.gov/pubmed/21144973

 

Cannabidiol lowers incidence of diabetes in non-obese diabetic mice.

https://www.ncbi.nlm.nih.gov/pubmed/16698671

 

Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes.

https://www.ncbi.nlm.nih.gov/pubmed/16400026

 

Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation.

https://www.ncbi.nlm.nih.gov/pubmed/21537423

 

The endocannabinoid system in obesity and type 2 diabetes

https://www.ncbi.nlm.nih.gov/pubmed/18563385

 

Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes.

https://www.ncbi.nlm.nih.gov/pubmed/21484568

 

The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications.

https://www.ncbi.nlm.nih.gov/pubmed/22155112

Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain.

https://www.ncbi.nlm.nih.gov/pubmed/20236533

 

Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study

https://www.ncbi.nlm.nih.gov/pubmed/27573936
 

Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes.

https://www.ncbi.nlm.nih.gov/pubmed/16400026